Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
5.70
-0.06 (-1.04%)
Apr 1, 2025, 4:00 PM EDT - Market closed
Neuphoria Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Cash & Equivalents | 4.34 | 12.61 | 12.1 | 33.56 | 28.5 | 4.58 | Upgrade
|
| Cash & Short-Term Investments | 4.34 | 12.61 | 12.1 | 33.56 | 28.5 | 4.58 | Upgrade
|
| Cash Growth | -57.13% | 4.17% | -63.94% | 17.77% | 522.56% | -67.27% | Upgrade
|
| Accounts Receivable | - | - | - | - | 0.19 | 0.02 | Upgrade
|
| Other Receivables | 0.04 | 0.13 | 0.43 | 6.78 | 0.94 | 2.96 | Upgrade
|
| Receivables | 0.04 | 0.13 | 0.43 | 6.78 | 1.13 | 2.98 | Upgrade
|
| Prepaid Expenses | 0.02 | 0.46 | 0.8 | 1.46 | 0.86 | 0.77 | Upgrade
|
| Restricted Cash | - | - | - | - | 0.44 | - | Upgrade
|
| Total Current Assets | 4.4 | 13.19 | 13.33 | 41.81 | 30.93 | 8.33 | Upgrade
|
| Property, Plant & Equipment | 0.15 | 0.22 | 0.33 | 0.67 | 0.87 | 1.05 | Upgrade
|
| Goodwill | 8.41 | 8.69 | 8.69 | 12.87 | 12.4 | 12.87 | Upgrade
|
| Other Intangible Assets | 5.14 | 5.47 | 6.13 | 9.84 | 9.95 | 11.77 | Upgrade
|
| Other Long-Term Assets | 0.07 | 0.08 | 0.08 | 0.12 | 0.12 | 0.44 | Upgrade
|
| Total Assets | 18.17 | 27.65 | 28.56 | 65.31 | 54.26 | 34.46 | Upgrade
|
| Accounts Payable | 1.53 | 2.24 | 1.44 | 1.56 | 1.03 | 1.26 | Upgrade
|
| Accrued Expenses | 0.48 | 1.46 | 1.19 | 1.64 | 1.16 | 1.06 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | - | 5.19 | Upgrade
|
| Current Portion of Leases | 0.12 | 0.12 | 0.11 | 0.16 | 0.17 | 0.77 | Upgrade
|
| Total Current Liabilities | 2.13 | 3.83 | 2.74 | 3.36 | 2.36 | 8.27 | Upgrade
|
| Long-Term Debt | - | - | - | - | - | 6.26 | Upgrade
|
| Long-Term Leases | 0.05 | 0.12 | 0.24 | 0.53 | 0.69 | 0.03 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.84 | 0.96 | 1.1 | 1.8 | 1.84 | 2.2 | Upgrade
|
| Other Long-Term Liabilities | 1.39 | 5.25 | 2.47 | 2.7 | 1.76 | 4.98 | Upgrade
|
| Total Liabilities | 4.42 | 10.16 | 6.55 | 8.4 | 6.67 | 21.78 | Upgrade
|
| Common Stock | 0 | - | - | 217.7 | 190.19 | 148.16 | Upgrade
|
| Additional Paid-In Capital | 198.19 | 198.48 | 187.55 | - | - | - | Upgrade
|
| Retained Earnings | -180.73 | -177.98 | -162.48 | -173.31 | -154.04 | -148.89 | Upgrade
|
| Comprehensive Income & Other | -3.72 | -3.01 | -3.06 | 12.52 | 11.45 | 13.41 | Upgrade
|
| Shareholders' Equity | 13.75 | 17.49 | 22.01 | 56.91 | 47.6 | 12.68 | Upgrade
|
| Total Liabilities & Equity | 18.17 | 27.65 | 28.56 | 65.31 | 54.26 | 34.46 | Upgrade
|
| Total Debt | 0.17 | 0.24 | 0.35 | 0.69 | 0.87 | 12.24 | Upgrade
|
| Net Cash (Debt) | 4.18 | 12.37 | 11.75 | 32.87 | 27.63 | -7.66 | Upgrade
|
| Net Cash Growth | -53.92% | 5.27% | -64.26% | 18.96% | - | - | Upgrade
|
| Net Cash Per Share | 0.00 | 0.01 | 0.01 | 0.02 | 0.04 | -0.01 | Upgrade
|
| Filing Date Shares Outstanding | 1.76 | 3,118 | 1,469 | 1,353 | 1,008 | 626.19 | Upgrade
|
| Total Common Shares Outstanding | 1.63 | 2,385 | 1,469 | 1,353 | 1,008 | 626.19 | Upgrade
|
| Working Capital | 2.26 | 9.36 | 10.59 | 38.45 | 28.57 | 0.06 | Upgrade
|
| Book Value Per Share | 8.44 | 0.01 | 0.01 | 0.04 | 0.05 | 0.02 | Upgrade
|
| Tangible Book Value | 0.2 | 3.33 | 7.19 | 34.21 | 25.25 | -11.96 | Upgrade
|
| Tangible Book Value Per Share | 0.13 | 0.00 | 0.00 | 0.03 | 0.03 | -0.02 | Upgrade
|
| Machinery | - | - | - | - | 0.11 | 1.37 | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.